| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |